Re-expression of fetal genes has been considered to underlie ionic remodeling in diseased heart. T-type Ca 2+ channels have been reported to be functionally expressed in embryonic hearts. In this review, we summarize developmental changes of T-type Ca 2+ channels in mouse ventricles from 9.5 days postcoitum (dpc) to adulthood, using patch clamp and quantitative PCR. In addition, we introduced T-type Ca 2+ channel expression in hypertrophied ventricles caused by myocardial infarction (MI) and aortic banding (AOB). Substantial T-type Ca 2+ channel current was recorded at both 9.5 and 18 dpc. The currents were inhibited by Ni 2+ at low concentrations. The current was not detectable in the adult stage. Ca v 3.2 (α 1H ) mRNA is expressed dominantly at both 9.5 and 18 dpc. Ca v 3.1 (α 1G ) increases from 9.5 to 18 dpc, but remains at low level compared with Ca v 3.2. In contrast, Ca v 3.1 is greater than Ca v 3.2 at the adult stage. In MI, Ca v 3.1 mRNA correlates negatively with brain natriuretic peptide (BNP) mRNA, whereas Ca v 3.2 mRNA correlates positively with BNP mRNA. In AOB, these correlations are weak. We also analyzed the neuron-restrictive silencer factor (NRSF) in these hearts because it is the suppressor of transcription of the fetal cardiac gene program. The negative correlation between NRSF and BNP was stronger in MI than in AOB. Our findings show that Ca v 3.2 underlies the functional T-type Ca 2+ channel in embryonic heart and suggest that NRSF may regulate Ca v 3.2 expression in diseased hearts.
Introduction
Cardiac remodeling, including electrical remodeling is a key factor in pathophysiological processes such as hypertrophy and heart failure (1, 2). This remodeling exacerbates cardiac function and is associated with arrhythmias. The mechanism of cardiac remodeling has been considered to be a recapitulation of a fetal cardiac gene program, including up-regulation of β-myosin heavy chain and BNP (brain natriuretic peptide) (2). The (re)expression of fetal-type ion channels probably pro-duces electrical remodeling (Fig. 1) .
Cardiac ventricles at the early-embryonic stage beat spontaneously and regularly and lose this spontaneous activity with development (3, 4) . T-type Ca 2+ channels play an important role in pacemaking activity of adult sinus node (5). T-type Ca 2+ channels have been reported to contribute to electrical activity in the early-embryonic heart as well (6) . In addition, T-type Ca 2+ channel current has been shown to reappear in ventricular myocytes under some pathological processes such as ventricular hypertrophy (7, 8) and post-myocardial infarction (9) . In this paper, we describe the expression of T-type Ca 2+ channels in fetal and diseased mouse heart. In addition, a regulatory factor of electrical remodeling in diseased hearts is discussed. The relationship between development of ion channels and electrical remodeling is also briefly reviewed.
T-type Ca 2+ channel in mouse embryonic heart T-type Ca 2+ channel current has been previously described in embryonic ventricular cells (10) . Recent advances in molecular biological studies have identified three different subtypes of genes encoding α 1 subunits of T-type Ca 2+ channels: Ca v 3.1 (α 1G ), Ca v 3.2 (α 1H ), and Ca v 3.3 (α 1I ) (11 -13) . Ca v 3.1 and Ca v 3.2 are expressed in adult hearts (11, 13) and Ca v 3.1 is detected in the brain (12) . The subtype distribution in cardiac ventricles is also dependent on the developmental stage (14) . Cribbs et al. (15) have reported that Ca v 3.1 underlies functional T-type Ca 2+ channels in mouse hearts at middle embryonic stage. In rat hearts at middle embryonic to perinatal stages, both Ca v 3.1 and Ca v 3.2 participate in the functional T-type Ca 2+ channels (16) . Thus, the subtype distribution of T-type Ca 2+ channels with development remains controversial and may also be species-dependent. Therefore, we studied the subtype of functional T-type Ca 2+ channels in mouse hearts at earlier embryonic stages (6) .
The existence of T-type Ca 2+ channel current in mouse cardiac ventricle during the embryonic period was studied by the whole-cell patch clamp technique. L-and T-type Ca 2+ channel currents were separated by applying depolarization pulses to different test potentials from holding potentials of −100 and −50 mV. Isolation of Ttype Ca 2+ channel current was performed by subtracting the currents obtained at the same test potential, but from different holding potentials. Figure 2 shows these T-type Ca 2+ channel currents obtained by subtraction in the mouse cardiac ventricular cells at 9.5 days postcoitum (dpc). Figure 2A shows the current traces in a typical experiment; and Fig. 2B shows the voltage-peak current relationships of the currents obtained at a holding potential of −100 mV (T-type plus L-type Ca 2+ current), at a holding potential of −50 mV (L-type Ca 2+ current), and the difference current (T-type Ca 2+ current) at the three stages of development (9.5 dpc, 18 dpc, and adult). In ventricular myocytes at the embryonic stages (9.5 and 18 dpc), substantial T-type Ca 2+ channel currents were recorded, but not at adulthood.
Functional expression studies of Ca v 3.1, Ca v 3.2, and Ca v 3.3 cDNAs in heterologous systems has revealed that they each possess distinct properties (17, 18) . We analyzed the characteristics of T-type Ca 2+ channel current in ventricular myocytes both at 9.5 and 18 dpc. Table 1 summarizes the kinetics and Ni 2+ sensitivity of T-type Ca 2+ channel current. There were no significant differences in channel functions between 9.5 and 18 dpc. In addition, T-type Ca 2+ channels were very sensitive to Ni 2+ (IC 50 : 31 ± 4 µM at 9.5 dpc and 26 ± 5 µM at 18 dpc). Lee et al. (19) have reported that Ni 2+ at low concentration blocks Ca v 3.2 current more effectively than Ca v 3.1 current and Ca v 3.3 current (IC 50 : 250 µM for Ca v 3.1, 12 µM for Ca v 3.2, 216 µM for Ca v 3.3). Electrophysiological data indicate that Ca v 3.2 underlies functional T-type Ca 2+ current in mouse ventricles during the embryonic period.
We quantified developmental changes of Ca v 3.1 and Ca v 3.2 mRNAs expression using mouse ventricles at 9.5 dpc, 18 dpc, and adult stage ( Fig. 3 ). At 9.5 dpc, Ca v 3.2 mRNA is virtually exclusively expressed. With development, Ca v 3.2 mRNA expression reduces, whereas Ca v 3.1 mRNA expression increases, although at 18 dpc Ca v 3.2 mRNA is still dominant. In the adult, there is Ca v 3.1 mRNA expression with minimal Ca v 3.2 mRNA expression. We conclude that in mouse embryonic ventricles, the Ca v 3.2 gene is translated into the functional T-type channels, whereas Ca v 3.1 mRNA exists from the late embryonic till the adult stage, but does not produce relevant Ca 2+ channel protein function.
T-type Ca 2+ channel in mouse diseased hearts T-type Ca 2+ channels are down-regulated in normal adult cardiac ventricles (6) . Under pathological conditions such as pressure-overload cardiac hypertrophy, myocardial infarction and heart failure (7 -9) , T-type Ca 2+ channels have been reported to be re-expressed in ventricle. This increased T-type Ca 2+ channel current shows relatively high Ni 2+ sensitivity (7) , which suggests that the Ca v 3.2 gene underlies this re-expressed T-type Ca 2+ channel. However, in a molecular biological study, up-regulation of Ca v 3.1 mRNA has been reported (9) . Thus, the nature of T-type Ca 2+ channel upregulation in diseased hearts remains unclear.
To clarify this issue, we investigated mRNA expression of the T-type Ca 2+ channel subtype genes in cardiac ventricles in post-myocardial infarction mouse hearts (MI) and hypertrophied mouse hearts by aortic banding (AOB). The myocardial infarction model was made by ligation of the left anterior descending artery. The aortic banding model was produced by banding of the aortic arch between the carotid arteries. We examined mRNA levels of Ca v 3.1, Ca v 3.2, and BNP in hypertrophied ventricular septum of MI and AOB. In MI, Ca v 3.1 mRNA decreased (55.7% vs control), but Ca v 3.2 mRNA expression increased (142% vs control). In AOB, Ca v 3.1 mRNA decreased (76.9% vs control), but Ca v 3.2 mRNA expression was comparable to the control (Fig. 4) . In MI, Ca v 3.1 mRNA correlates negatively with BNP mRNA, whereas Ca v 3.2 mRNA correlates positively with BNP mRNA (data not shown). In AOB, there were poor or no correlations between Ca v 3.1 mRNA or Ca v 3.2 mRNA and BNP mRNA, respectively (data not shown).
Kuwabara et al. (20) have reported that neuronrestrictive silencer factor (NRSF) is a transcriptional regulator of the fetal cardiac gene program. NRSF binds a neuron-restrictive silencer element (NRSE, consensus sequence: TTTCAGCACCACGGACAGCGCC) in genes and suppresses the expression of fetal cardiac genes. Because, interestingly, NRSE exists in the untranslated regions of the BNP and Ca v 3.2 genes (20, 21) , the changes of BNP and Ca v 3.2 mRNA expressions in diseased hearts might be regulated by NRSF. To study the role of NRSF on mRNA expression in diseased hearts, we investigated the expression of NRSF mRNA in hypertrophied ventricular septum in the MI and AOB models (Fig. 5) . Although there were negative correlations between BNP mRNA and NRSF mRNA in both models, the negative correlation between NRSF and BNP was stronger in MI than in AOB. In MI, NRSF is strongly down-regulated and fetal cardiac genes such as BNP and Ca v 3.2 are therefore up-regulated. These findings suggest that NRSF may play an important role in electrical remodeling in infarcted hearts and to a lesser degree also in hypertrophied hearts caused by aortic banding.
Developmental changes of cardiac ion channels
Fetal gene expression such as β-myosin heavy chain and BNP have been reported in cardiac hypertrophy and in heart failure (22) . Alternation of ion channel gene expression observed in diseased hearts may result from Recovery from inactivation τfast 37.2 ± 6.9 276 ± 21 τslow 26.9 ± 5.0 (n = 6) 300 ± 23 (n = 8)
IC50 of Ni 2+ block (µM) 31 ± 4 (n = 10) 26 ± 5 (n = 7)
Time course of activation and inactivation were measured at depolarization to −40 from −100 mV. Curves of steadystate activation and inactivation were fitted to a Boltzmann equation.V0.5 is the potential to give a half-value and k is the slope factor, which determines the steepness of the curves. Time-dependency of recovery from inactivation was studied. The relative currents to the peak current were plotted as a function the interpulse duration. The relations were fitted by a double exponential function. ) and I f (30, 31) , which constitutes re-expression of fetal ion channels, have been described. These changes may destabilize the resting membrane potential and thus increase the propensity to arrhythmias in ventricular myocytes in diseased hearts. Sarcoplasmic reticulum (SR)-related proteins including the ryanodine receptor (RyR2), the SR Ca 2+ pump (SERCA2), and the Na + / Ca 2+ exchanger (NCX1) regulate Ca 2+ homeostasis in adult cardiac ventricle (32) . SR-related proteins are little expressed and NCX1 is well developed at the early-embryonic stage. At the adult stage, SR-related proteins are expressed well, whereas NCX1 declines (33, 34) . In remodeling of diseased hearts, these Ca handling proteins also show a pattern familiar to that during embryonic development (35) . The alteration of Ca homeostasis is considered to exacerbate cardiac function and as well as the propensity to arrhythmias.
Conclusion T-type Ca 2+ channels function in mouse cardiac ventricles during the embryonic period and the Ca v 3.2 gene is responsible for these functional channels. In hypertrophied ventricle in MI, Ca v 3.2 and BNP mRNA expressions are both up-regulated. NRSF mRNA expression is negatively correlated to BNP mRNA expression. In MI, NRSF might be a regulatory factor for re-capitulation of fetal genes. As shown in Fig. 6 , various changes of ion channel expression exist during the development of the heart. To clarify the mechanisms of electrical remodeling in diseased hearts, further studies to find a transcriptional regulator for fetal cardiac gene program such as NRSF will be necessary. 
